1-3 of 3
Karolin Guldevall
Close
Save search
Sort by
Journal Articles

Efficient Scale-up and Pre-Clinical Evaluation of NKG2C+ Adaptive NK Cell Expansion for Therapy Against High-Risk AML/MDS

Free
Ebba Sohlberg, PhD, Alvaro Haroun-Izquierdo, Andreas T Björklund, MD PhD MSc, Sarah Cooley, MD, Merete Thune Wiiger, Msc, Jodie Peter Goodridge, PhD, Hanna Julie Hoel, Aline Pfefferle, Michael Chrobook, Veronika Kremer, Eva Hellström-Lindberg, MD PhD, Eivind Heggernes Ask, Blomberg Pontus, Bahram Valamehr, PhD, Karolin Guldevall, Hanna van Ooijen, Bjorn Onfelt, Evren Alici, MD PhD, Hans-Gustaf Ljunggren, Jeffrey S. Miller, MD, Karl-Johan Malmberg, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 195.
https://doi.org/10.1182/blood-2018-195
Published: 2018
Journal Articles

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

Free
Martin Felices, PhD, Dhifaf Sarhan, PhD, Ludwig Brandt, Karolin Guldevall, Ron McElmurry, Alexander Lenvik, Sami Chu, Jakub Tolar, MD PhD, Elizabeth Taras, Stephen R Spellman, MS, Erica D. Warlick, MD, Michael R. Verneris, MD, Sarah Cooley, MD, Daniel Weisdorf, MD, Bruce R. Blazar, MD, Bjorn Onfelt, PhD, Dan Vallera, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2016) 128 (22): 4291.
https://doi.org/10.1182/blood.V128.22.4291.4291
Published: 2016
Journal Articles

Classification of human natural killer cells based on migration behavior and cytotoxic response

Free
Bruno Vanherberghen, Per E. Olofsson, Elin Forslund, Michal Sternberg-Simon, Mohammad Ali Khorshidi, Simon Pacouret, Karolin Guldevall, Monika Enqvist, Karl-Johan Malmberg, Ramit Mehr, Björn Önfelt
Journal: Blood
Blood (2013) 121 (8): 1326–1334.
https://doi.org/10.1182/blood-2012-06-439851
Published: 2013
Includes: Supplemental data